PHARMACISTS, specialists and GPs will be offered a comprehensive medicinal cannabis educational program by fledgling provider MedReleaf as part of the company's entry into the Australian market (PD 02 Feb).
The resources are currently under development by NPS MedicineWise offshoot VentureWise, with the aim of not only educating the sector about medicinal cannabis but also "building confidence in MedReleaf's specific formulations".
MedReleaf Australia was recently granted import licences by the Office of Drug Control, and is now taking orders from Australian pharmacies and hospitals with product anticipated to be available before the end of next month.
The company plans to import medicinal cannabis oils and capsules as well as dried plant, manufactured in Canada, while it constructs its own manufacturing facility in south-east Queensland.
A manufacturing licence is also currently under assessment.
MedReleaf Corp is traded on the Toronto Stock Exchange, while the local operation is a joint venture company headed up by pharmacist Russell Harding.
He said MedReleaf Australia aims to establish itself as a "world class vertically integrated medicinal cannabis company," adding that he hopes the products will in due course become listed on the ARTG and ultimately on the PBS.
See medreleafaustralia.com.au.
The above article was sent to subscribers in Pharmacy Daily's issue from 06 Feb 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 06 Feb 18
